Radiation oncology company, Accuray declared that the CyberKnife Robotic Radiosurgery System is being used by the CHRISTUS MUGUERZA Hospital Alta Especialidad to treat cancer patients. The hospital, based in Monterrey, Mexico, is the first center in the country to offer the advantages of the CyberKnife System to cancer patients.
The CyberKnife Robotic Radiosurgery System is a non-invasive technique used to treat both cancer and non-cancerous lesions in the body, including lung, head and neck, intracranial, pancreatic and prostate tumors. The system delivers effective doses of radiation with optimal precision. It is capable of tracking and correcting erratic tumor movements, which in turn reduce radiation contact to healthy tissues and also eliminates the side effects that are generally linked with other radiation techniques.
CHRISTUS MUGUERZA had started treating patients in October last year. So far, with the help of the CyberKnife Robotic Radiosurgery System, the hospital has treated eight patients with non-cancerous lesions or malignant tumors in the head, neck brain and kidneys. The hospital had administered stereotactic radiosurgery and stereotactic body radiation therapy using the CyberKnife Robotic Radiosurgery System, thus providing a new treatment choice for cancer patients across the region.
According to Euan S. Thomson, Ph.D., President and Chief Executive Officer of Accuray, the installation of the CyberKnife System in Mexico shows the company’s commitment to expand its position in other markets. So far, over 100,000 patients across the globe have been treated with the CyberKnife System and the company is happy to extend the advantages of stereotactic radiosurgery and stereotactic body radiation therapy to patients in Mexico, Thomson said.